Precision Biosciences Stock Performance
| DTIL Stock | USD 9.82 0.41 4.01% |
The company holds a Beta of 0.26, which implies not very significant fluctuations relative to the market. As returns on the market increase, Precision BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Precision BioSciences is expected to be smaller as well. Precision BioSciences right now holds a risk of 6.95%. Please check Precision BioSciences standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Precision BioSciences will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Over the last 90 days Precision BioSciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward indicators, Precision BioSciences is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (2.64) | Five Day Return (5.23) | Year To Date Return (10.27) | Ten Year Return (98.10) | All Time Return (98.10) |
Last Split Factor 1:30 | Last Split Date 2024-02-14 |
1 | Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences | 02/20/2024 |
2 | iECURE Secures Approval from U.K. Medicines Healthcare Products Regulatory Agency to Expand the OTC-HOPE Study of ECUR-506 | 03/06/2024 |
3 | Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy | 03/19/2024 |
4 | Acquisition by John Kelly of 20000 shares of Precision BioSciences at 0.86 subject to Rule 16b-3 | 03/22/2024 |
5 | DTIL Stock Earnings Precision BioSciences Misses EPS, Misses Revenue for Q4 2023 | 03/27/2024 |
6 | What is the Markets View on Precision BioSciences Inc Stocks Price and Volume Trends Thursday - InvestorsObserver | 03/28/2024 |
7 | Wall Street Analysts Predict a 407.94 percent Upside in Precision BioSciences Heres What You Should Know | 04/02/2024 |
8 | Precision BioSciences, Inc. Revenue Breakdown NASDAQDTIL TradingView - TradingView | 04/10/2024 |
9 | Precision BioSciences, Inc. Short Interest Up 62.3 percent in March - MarketBeat | 04/12/2024 |
10 | Eli Lilly subsidiary ends lucrative collaboration with Durham biotech | 04/18/2024 |
| Begin Period Cash Flow | 189.6 M |
Precision |
Precision BioSciences Relative Risk vs. Return Landscape
If you would invest 1,089 in Precision BioSciences on January 25, 2024 and sell it today you would lose (107.00) from holding Precision BioSciences or give up 9.83% of portfolio value over 90 days. Precision BioSciences is currently generating 0.0884% in daily expected returns and assumes 6.9519% risk (volatility on return distribution) over the 90 days horizon. In different words, 61% of stocks are less volatile than Precision, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Precision BioSciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Precision BioSciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Precision BioSciences, and traders can use it to determine the average amount a Precision BioSciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0127
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | DTIL |
| Negative Returns |
Estimated Market Risk
| 6.95 actual daily | 61 61% of assets are less volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Precision BioSciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Precision BioSciences by adding Precision BioSciences to a well-diversified portfolio.
Precision BioSciences Fundamentals Growth
Precision Stock prices reflect investors' perceptions of the future prospects and financial health of Precision BioSciences, and Precision BioSciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Precision Stock performance.
| Return On Equity | -1.07 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (1.26) % | ||||
| Operating Margin | (2.12) % | ||||
| Current Valuation | (14.66 M) | ||||
| Shares Outstanding | 6.92 M | ||||
| Price To Earning | (6.10) X | ||||
| Price To Book | 5.18 X | ||||
| Price To Sales | 2.00 X | ||||
| Revenue | 48.73 M | ||||
| Gross Profit | 25.1 M | ||||
| EBITDA | (35.48 M) | ||||
| Net Income | (42.53 M) | ||||
| Cash And Equivalents | 184.14 M | ||||
| Cash Per Share | 1.66 X | ||||
| Total Debt | 31.27 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 4.59 X | ||||
| Book Value Per Share | 4.53 X | ||||
| Cash Flow From Operations | (84.11 M) | ||||
| Earnings Per Share | (332.12) X | ||||
| Market Capitalization | 70.75 M | ||||
| Total Asset | 159.78 M | ||||
| Retained Earnings | (489.63 M) | ||||
| Working Capital | 86.37 M | ||||
| Current Asset | 174.05 M | ||||
| Current Liabilities | 23.86 M | ||||
About Precision BioSciences Performance
To evaluate Precision BioSciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Precision BioSciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Precision Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Precision BioSciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Precision's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 275.53 | 244.91 | |
| Return On Tangible Assets | (0.44) | (0.46) | |
| Return On Capital Employed | (0.40) | (0.42) | |
| Return On Assets | (0.44) | (0.46) | |
| Return On Equity | (3.70) | (3.51) |
Things to note about Precision BioSciences performance evaluation
Checking the ongoing alerts about Precision BioSciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Precision BioSciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Precision BioSciences had very high historical volatility over the last 90 days | |
| Precision BioSciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 48.73 M. Net Loss for the year was (42.53 M) with profit before overhead, payroll, taxes, and interest of 25.1 M. | |
| Precision BioSciences currently holds about 184.14 M in cash with (84.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. | |
| Latest headline from bizjournals.com: Eli Lilly subsidiary ends lucrative collaboration with Durham biotech |
- Analyzing Precision BioSciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Precision BioSciences' stock is overvalued or undervalued compared to its peers.
- Examining Precision BioSciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Precision BioSciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Precision BioSciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Precision BioSciences' stock. These opinions can provide insight into Precision BioSciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Precision BioSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (332.12) | Revenue Per Share 12.685 | Quarterly Revenue Growth (0.34) | Return On Assets (0.14) | Return On Equity (1.07) |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.